Solventum Corp | SOLV - Interest Expense On Debt


Solventum Corp reported $14.1B in Interest Expense on Debt for its fiscal quarter ending in March of 2026.





Interest Expense On Debt Change Date
Abbott USD 68M 26M Mar/2026
Align Technology USD 16.04M 14.04M Dec/2025
Baxter International USD 58M 14M Sep/2025
Becton, Dickinson and Co. USD 149M 4M Mar/2026
Cencora USD 78.36B 78.25B Dec/2025
Dexcom USD 4.2M 500K Dec/2025
Insulet USD 14.7M 5.5M Mar/2026
Solventum Corp USD 14.1B 14.05B Mar/2026
West Pharmaceutical Services USD 1.9M 1.7M Mar/2026
Zimmer Biomet Holdings USD 68.8M 3.1M Mar/2026